Lysis onset time as diagnostic rotational thromboelastometry parameter for fast detection of hyperfibrinolysis

Anesthesiology

Volumn 121, Issue 1, 2014, Pages 89-97

  Dekker, Simone Esther ^a   Viersen, Victor Alexander ^a   Duvekot, Anne ^a   De Jong, Merijn ^a   Van Den Brom, Charissa Esmé ^a   Van De Ven, Peter M ^b   Schober, Patrick ^a   Boer, Christa ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; APROTININ; CITRIC ACID; D DIMER; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS EQUIPMENT; BLOOD CLOT LYSIS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HEMATOLOGICAL PROCEDURE; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; IMPEDANCE AGGREGOMETRY; INTERNATIONAL NORMALIZED RATIO; LYSIS ONSET TIME; MALE; MEDICAL DEVICE; NORMAL HUMAN; OBSERVATIONAL STUDY; OUT OF HOSPITAL CARDIAC ARREST; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME; RESUSCITATION; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TIME; WHOLE BLOOD ELECTRICAL IMPEDANCE AGGREGOMETRY;

ADULT; AGED; BLOOD CIRCULATION TIME; CARDIOPULMONARY RESUSCITATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYSIS; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PROSPECTIVE STUDIES; REFERENCE VALUES; THROMBELASTOGRAPHY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84902872748     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000229     Document Type: Article

References (21)

1. Rijken DC, Lijnen HR: New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost 2009; 7:4-13
2. Schöchl H, Frietsch T, Pavelka M, Jámbor C: Hyperfibrinolysis after major trauma: Differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67:125-31
3. Ives C, Inaba K, Branco BC, Okoye O, Schochl H, Talving P, Lam L, Shulman I, Nelson J, Demetriades D: Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215:496-502
4. Viersen VA, Greuters S, Korfage AR, Van der Rijst C, Van Bochove V, Nanayakkara PW, Vandewalle E, Boer C: Hyperfibrinolysis in out of hospital cardiac arrest is associated with markers of hypoperfusion. Resuscitation 2012; 83:1451-5
5. Schöchl H, Cadamuro J, Seidl S, Franz A, Solomon C, Schlimp CJ, Ziegler B: Hyperfibrinolysis is common in out- of-hospital cardiac arrest: Results from a prospective observational thromboelastometry study. Resuscitation 2013; 84:454-9
6. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF: Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64:1211-7; discussion 1217
7. Chen LY, Mehta JL: Lys- and glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation. Thromb Res 1994; 74:555-63
8. Callahan KP, Malinin AI, Gurbel PA, Alexander JH, Granger CB, Serebruany VL: Platelet function and fibrinolytic agents: Two sides of a coin? Cardiology 2001; 95:55-60
9. Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA: Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: Effects on surface proteins and platelet aggregation. Blood 1986; 68:275-80
10. Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W: Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113:1003-12
11. Nielsen VG, Cohen BM, Cohen E: Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006; 17:75-81
12. Kupesiz A, Rajpurkar M, Warrier I, Hollon W, Tosun O, Lusher J, Chitlur M: Tissue plasminogen activator induced fibrinolysis: Standardization of method using thromboelastography. Blood Coagul Fibrinolysis 2010; 21:320-4
13. Ganter MT, Hofer CK: Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-75
14. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA: The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108:751-8
15. Jámbor C, Görlinger K: Use of antifibrinolytics in massive transfusion. Anasth Intensivmed 2007; 48:S167-73
16. Meh DA, Mosesson MW, DiOrio JP, Siebenlist KR, Hernandez I, Amrani DL, Stojanovich L: Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis 2001; 12:627-37
17. Berridge DC, Burgess-Wilson ME, Westby JC, Hopkinson BR, Makin GS: Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation. Br J Surg 1989; 76:1026-30
18. Serebruany VL, Malinin AI, Callahan KP, Binbrek A, Van De Werf F, Alexander JH, Granger CB, Gurbel PA; Assessment of the Safety and Efficacy of a New Thrombolytic Agent platelet substudy: Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy. Am Heart J 2003; 145:636-42
19. Panes O, Padilla O, Matus V, Sáez CG, Berkovits A, Pereira J, Mezzano D: Clot lysis time in platelet-rich plasma: Method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid. Platelets 2012; 23:36-44
20. Genét GF, Ostrowski SR, Sørensen AM, Johansson PI: Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 2012; 18:638-44
21. Dirkmann D, Radü-Berlemann J, Görlinger K, Peters J: Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid. J Trauma Acute Care Surg 2013; 74:482-8